Gengraf is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Cyclosporine.
Product ID | 0074-3109_4abab0be-cf15-0095-c5ad-fcc3bf039d4f |
NDC | 0074-3109 |
Product Type | Human Prescription Drug |
Proprietary Name | Gengraf |
Generic Name | Cyclosporine |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2015-11-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA065003 |
Labeler Name | AbbVie Inc. |
Substance Name | CYCLOSPORINE |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2015-11-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA065003 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-11-01 |
Ingredient | Strength |
---|---|
CYCLOSPORINE | 100 mg/1 |
SPL SET ID: | e896cbfe-4745-4088-82a3-8dc10b75c41f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0074-3108 | Gengraf | Cyclosporine |
0074-3109 | Gengraf | Cyclosporine |
0074-7269 | Gengraf | Cyclosporine |
0078-0246 | Neoral | cyclosporine |
0078-0248 | Neoral | cyclosporine |
0023-9163 | RESTASIS | cyclosporine |
0023-5301 | Restasis MultiDose | cyclosporine |
0078-0109 | Sandimmune | cyclosporine |
0078-0110 | Sandimmune | cyclosporine |
0078-0240 | Sandimmune | cyclosporine |
0078-0241 | Sandimmune | cyclosporine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GENGRAF 75387943 2441241 Live/Registered |
ABBVIE INC. 1997-11-10 |